# Citations for Research Query

**Query:** # Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** Microtubule-Dependent Neuronal Migration Failure Module
- **Category:** Module

## Target Hypothesis
- **Hypothesis ID:** microtubule_migration_model
- **Hypothesis Label:** Microtubule-Dependent Neuronal Migration Model
- **Status in KB:** CANONICAL

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: microtubule_migration_model
hypothesis_label: Microtubule-Dependent Neuronal Migration Model
status: CANONICAL
description: Microtubule-associated proteins, tubulin subunits, dynein, and kinesin motors form a coupled
  apparatus for neuronal polarization, nucleokinesis, migration, and projection outgrowth. Pathogenic
  variants disrupt this apparatus through altered microtubule polymerization, heterodimer formation, MAP
  binding, motor ATPase activity, microtubule binding, or cargo/centrosome-nucleus coupling. Developing
  neurons then fail to migrate to appropriate cortical positions, producing dyslamination, lissencephaly/subcortical-band-heterotopia
  patterns, and selected polymicrogyria-like cortical malformations.
evidence:
- reference: PMID:23603762
  supports: SUPPORT
  evidence_source: OTHER
  snippet: Our data reinforce the importance of centrosomal and microtubule-related proteins in cortical
    development and strongly suggest that microtubule-dependent mitotic and postmitotic processes are
    major contributors to the pathogenesis of MCD.
  explanation: Broad synthesis from human genetics, biochemical assays, yeast assays, and mouse in utero
    experiments supporting the module-level mechanism.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce artifact-friendly outputs such as an
evidence matrix, mechanistic diagram, knowledge-gap table, or comparison table.
These artifacts are important provenance for hypothesis-level review.

**Provider:** falcon
**Generated:** 2026-06-09T22:27:42.895992

1. sebastien2023doublecortinrestrictsneuronal pages 1-3
2. viola2024radialgliaprogenitor pages 2-5
3. leca2023codonmodificationof pages 5-6
4. procopio2024phenotypicvariabilityin pages 2-4
5. goo2023schizophreniaassociatedmitoticarrest pages 1-2
6. goo2023schizophreniaassociatedmitoticarrest pages 4-5
7. ruizreig2024connectingneurodevelopmentto pages 1-2
8. ruizreig2024connectingneurodevelopmentto pages 4-5
9. ren2024lissencephalycausedby pages 2-4
10. ren2024lissencephalycausedby pages 4-6
11. ren2024lissencephalycausedby pages 1-2
12. procopio2024phenotypicvariabilityin pages 1-2
13. https://doi.org/10.1007/s00401-023-02665-y
14. https://doi.org/10.1083/jcb.202310157
15. https://doi.org/10.1101/2023.06.02.543327
16. https://doi.org/10.1038/s41380-022-01856-5
17. https://doi.org/10.1242/dev.201912
18. https://doi.org/10.1038/s41598-023-27782-2
19. https://doi.org/10.4103/1673-5374.375298
20. https://doi.org/10.3389/fped.2024.1367305
21. https://doi.org/10.3390/ijms25105505
22. https://doi.org/10.3389/fcell.2024.1478283
23. https://doi.org/10.1007/s00401-023-02665-y.
24. https://doi.org/10.1083/jcb.202310157.
25. https://doi.org/10.1101/2023.06.02.543327.
26. https://doi.org/10.1242/dev.201912.
27. https://doi.org/10.1038/s41380-022-01856-5.
28. https://doi.org/10.1007/s00401-023-02665-y,
29. https://doi.org/10.1083/jcb.202310157,
30. https://doi.org/10.1038/s41380-022-01856-5,
31. https://doi.org/10.1101/2023.06.02.543327,
32. https://doi.org/10.3389/fcell.2024.1478283,
33. https://doi.org/10.1242/dev.201912,
34. https://doi.org/10.1038/s41598-023-27782-2,
35. https://doi.org/10.4103/1673-5374.375298,
36. https://doi.org/10.3389/fped.2024.1367305,
37. https://doi.org/10.3390/ijms25105505,
38. https://doi.org/10.3390/cells13221882,
